Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche

Project Information

ELASTISLET

Grant agreement ID: 646075

DOI 10.3030/646075

Project closed

EC signature date 28 May 2015

Start date 1 June 2015

End date 31 May 2019

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials

Total cost € 6 214 495,00

EU contribution € 6 214 495,00

Coordinated by

UNIVERSIDAD DE VALLADOLID
Spain

• Biomaterial breakthrough offers hope to diabetes patients
  EN